Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

doctor-563428_960_720

100,000 vacancies contribute to NHS crisis

December 19, 2017 Manufacturing and Production, Medical Communications NHS, UK, biotech, drugs, nurses, pharma, pharmaceutical

Warning shots have been fired by both the General Medical Council (GMC) and the Labour Party about the recruitment issues …
News
novartis_window

Novartis snaps up Priority Review Voucher for $130m

December 18, 2017 Manufacturing and Production, Sales and Marketing Novartis, Ultragenyx, biotech, drugs, pharma, pharmaceutical

Novartis has got its wallet out to pick up a Priority Review Voucher (PRV) from Ultragenyx, forking out $130 million …
News
rare-disease-2888820_960_720

Rare disease medicines access faces a perfect storm

December 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …
News
teva_copy

Fierce local opposition to Teva’s restructure efforts

December 15, 2017 Manufacturing and Production, Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

When Kare Shultz decided to take on the CEO position at Teva he would have known that he was setting …
News
fullsizerender_2_rav

Working Life: Dr Rav Seeruthun, Medical Director of Roche UK

December 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …
Feature
mundipharma_4_204_of_291

Mundipharma names new President and CEO

December 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Napp, Napp Pharmaceuticals, appointment

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …
Appointment
fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017 Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …
News
money-2180330_960_720

Latest US company accused of price gouging, after 2,469% increase

December 12, 2017 Manufacturing and Production, Sales and Marketing Avondale Pharmaceutical, Niacor, biotech, drugs, pharma, pharmaceutical

It seems that no matter how much bad press comes their way, certain pharmaceutical companies are more than happy to …
News
shutterstock_212035546

Single, high-dose vaccine could provide better protection against cholera outbreaks, new research shows

December 12, 2017 Manufacturing and Production, Research and Development Africa, Asia, Caribbean, Cholera, Vaccine, paxvax, pharma

A team of researchers at the University of Maryland School of Medicine (UMSOM) has been assessing the effectiveness of a …
News
sanofi_new_paris_hq

Sanofi issues US-wide recall for arthritis product, after adverse events

December 12, 2017 Manufacturing and Production Sanofi, Synvisc-One, biotech, drugs, pharma, pharmaceutical

Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was …
News
brainss

Ionis scores huge breakthrough in Huntington’s, Roche licenses drug

December 12, 2017 Manufacturing and Production, Research and Development Ionis, Roche, biotech, drugs, pharma, pharmaceutical

Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …
News

Exscientia appoints Oxford Innovation Sciences founder and ex-Lansdowne CEO as Deputy Chairman

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Snow, Exscientia, appointment

Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …
Appointment
hands-600497_960_720

To succeed in emerging market medicine, anticipation and innovation are essential

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …
Feature
teva_small

Teva job cut rumours resurface, 10,000 expected

December 11, 2017 Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have …
News
The Gateway to Local Adoption Series

Latest content

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026